Dynamics of Renal Fibrosis Markers on the Basis of Complex  Treatment in Chronic Heart Failure with Anemia

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/1220

Full metadata record

DC Field	Value	Language
dc.contributor.author	Tosheva Khakima Bekmurodovna, Gadaev Abdigaffar Gadaevich	-
dc.date.accessioned	2021-12-28T08:47:53Z	-
dc.date.available	2021-12-28T08:47:53Z	-
dc.date.issued	2021	-
dc.identifier.issn	0033-3077	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/1220	-
dc.description.abstract	Renal fibrosis markers were evaluated in dynamics to study specific changes in the kidneys of patients with different hemodynamic types and functional classes of chronic heart failure with anemia and to evaluate the effectiveness of complex treatment. The renal fibrosis marker TGF-β1in the blood was 2591.0 ± 108.4 and 755.0 ± 18.87 pg / ml, respectively, in the absence of chronic heart failure and anemia (p˂0.001). This was indicative of a fibrosis process occurring in the kidney. After complex treatment with iron supplements, the TGF-β1index decreased by 2.25 times (p (0.001), the clinical condition, quality of life and endurance to physical activity changed significantly positively	en_US
dc.language.iso	en	en_US
dc.subject	chronic heart failure, chronic kidney disease, renal dysfunction, fibrosis markers, anemia, anemia, hemoglobin, iron in the blood, hemodynamic types	en_US
dc.title	Dynamics of Renal Fibrosis Markers on the Basis of Complex Treatment in Chronic Heart Failure with Anemia	en_US
dc.type	Article	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
6 Dynamics of renal fibrosis Markers on the Basis of Complex Treatment in Chronic Heart Failure with Anemia (SCOPUS).pdf		312.61 kB	Adobe PDF	View/Open

DSpace JSPUI